Ventus Therapeutics rallies $140m Series C

Ventus Therapeutics, Inc., a biopharmaceutical company, has raised $140 million in Series C financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this